What Instituto Americas does

Instituto Americas is a Brazilian clinical research and continuing medical education institution founded in 2008 (previously operating as Instituto COI de Educação e Pesquisa) and headquartered within the Americas Oncologia hospital complex in Barra da Tijuca, Rio de Janeiro, with a second research unit at Hospital Paulistano in São Paulo. The institute operates a unified portfolio comprising (1) a clinical research program running approximately 20 open prospective and retrospective studies in oncology and hematology (breast, lung, ovarian, prostate, colorectal, melanoma, multiple myeloma, Hodgkin lymphoma, CLL, AML); (2) the Ensino e Inovação continuing medical education program for physicians, nurses and researchers; (3) the PodCast Raízes educational content series; (4) the Horizontes da Saúde patient and caregiver education events; and (5) the Banco de Perucas (Wig Bank) patient support service operated with NGO Cabelegria.

The technical backbone is a centralized clinical research pharmacy with three Class II B2 biological safety cabinets, temperature-controlled thermolabile storage with 24/7 monitoring and email/mobile alert systems, a separate restricted-access investigational drug pharmacy staffed by two dedicated pharmacists, and an ICHOM-methodology Real-World Data platform implemented since 2016 that captures patient-reported outcomes using EORTC-QLQ-BR23 and EQ-5D-5L questionnaires. These capabilities support co-authorship on international Phase III studies (CEPHEUS at ASCO 2025, EMPOWER-Cervical, IKEMA) and publications in Nature Medicine, The Lancet Haematology, Annals of Oncology, Clinical Oncology and Cancers.

The institute's revenue mechanics rely primarily on per-patient fees from pharmaceutical sponsor trials (Novartis, Merck, SERVIER, GSK and others) routed through its two clinical units, supplemented by event and education sponsorship, while the Wig Bank and most educational content are delivered free of charge to patients and professionals. Customer segments are patients with cancer and hematologic malignancies seeking trial access, healthcare professionals seeking continued education, and pharmaceutical sponsors seeking Brazilian real-world evidence and trial enrollment. The institute operates as an affiliated entity within the Rede Américas / Americas Oncologia hospital network, which provides shared infrastructure including Hospital Vitória, Hospital Samaritano, Richet laboratory, HCOR radiotherapy, Delboni Auriemo and Cedimen.

Name

Instituto Americas

Legal name

Instituto Américas

Website

https://institutoamericas.org

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Instituto Americas is a Brazilian clinical research and medical education institution founded in 2008, operating within the Americas Oncologia hospital network to run approximately 20 open oncology and hematology clinical trials, deliver continuing medical education, and provide patient support services across Rio de Janeiro and São Paulo.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Other Scientific and Technical Consulting Services (54169), Medical and Diagnostic Laboratories (62151), Educational Services (611)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Oncology clinical research
• Clinical trial site management
• Continuing medical education
• Hematology research services
• Patient-reported outcomes

Headquarters

HQ city

Barra Da Tijuca

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Research Services: The institute conducts clinical trials (prospective and retrospective studies) in partnership with pharmaceutical companies and international research groups. These trials evaluate new therapies, treatment sequencing, and real-world outcomes in oncology, hematology, and other specialties. The institute contributes to international studies such as CEPHEUS (ASCO 2025), EMPOWER-Cervical, IKEMA, and others.
2. Continued Education and Training: The institute offers ongoing education programs (Ensino e Inovação) including updating courses and continued education for healthcare professionals in oncology, hematology, and other therapeutic areas.
3. Patient Care Services: Through the Americas Oncologia network, the institute supports patient consultations, treatments, chemotherapy, radiotherapy, and diagnostic imaging services at affiliated hospitals including Hospital Vitória (Rio de Janeiro) and Hospital Paulistano (São Paulo).

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Instituto Américas operates as a clinical research and education institution, conducting sponsored oncology, hematology, and multi-specialty clinical trials in partnership with pharmaceutical companies. It recruits patients into open studies, delivers continuing education for healthcare professionals, and runs patient support programs including the Banco de Perucas (Wig Bank). The institute also produces scientific publications and contributes as a co-author to international Phase III studies (e.g., CEPHEUS, EMPOWER-Cervical, IKEMA).

Product overview

Instituto Américas is a healthcare research and education institution that operates as a unified portfolio of clinical research, educational programs, and patient support services. The core offerings include Clinical Research programs conducting retrospective and prospective studies in oncology and hematology; Education and Innovation programs providing continuing education for healthcare professionals; Open Studies for patient recruitment into clinical trials; the PodCast Raízes educational content series; the Banco de Perucas patient support service providing wigs to cancer patients; and the Horizontes da Saúde educational event program. The institution maintains facilities in Rio de Janeiro and São Paulo, Brazil.

Differentiator

Problem solved

Functional benefit

Products and services

• Pesquisa Clínica (Clinical Research) Retrospective and prospective clinical research programs evaluating treatment outcomes and patient quality of life in oncology, hematology, and additional specialties, delivered in partnership with pharmaceutical sponsors and international research groups.
• Estudos Abertos (Open Studies / Clinical Trial Recruitment) Approximately 20 actively recruiting clinical trials across breast, ovarian, prostate, lung, colorectal cancer, melanoma, Hodgkin lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia, multiple myeloma, and other hematological malignancies. Open to patient recruitment in Rio de Janeiro and São Paulo.
• Ensino e Inovação (Education and Innovation) Continuing education courses and professional development programs for healthcare professionals in oncology, hematology, and additional specialties.
• Banco de Perucas (Wig Bank) Patient support service providing complimentary wigs, scarves, and turbans to cancer patients experiencing hair loss, operated in partnership with NGO Cabelegria. Registration by appointment at the Rio de Janeiro location.

Quantifiable outcome

• 95.3% 2-year survival rate for breast cancer patients (1,230 patients, 2012–2016)
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

14 partnerships are on record, tiered supporting, core and minor.

• GSKsupportingGTM or Marketing Partner · 1 January 2025Pharmaceutical company partner for podcast content on myelofibrose and real-world data with momelotinibe, featuring Dra. Cristiana Solza.
• ONG CabelegriasupportingStrategic or Co-development Partner · 1 January 2024Non-governmental organization partner for the Banco de Perucas (Wig Bank) program. Cabelegria provides wigs for cancer patients experiencing hair loss. This is the institute's first initiative outside research and education areas.
• SERVIERsupportingGTM or Marketing Partner · 1 January 2024Pharmaceutical company partner for the Simpósio Internacional Oncologia Americas 2024, featuring a special podcast on precision medicine in cholangiocarcinoma with Dr. Ana Paula Victorino.
• Oncologia AméricascoreStrategic or Co-development PartnerCore hospital network partner providing the clinical infrastructure (hospital beds, emergency departments, imaging, laboratory, radiotherapy) for the Instituto Américas' clinical research operations. Located within the Complexo Américas in Barra da Tijuca (Rio de Janeiro) with direct administrative support.
• Hospital Vitória (Rio de Janeiro)coreStrategic or Co-development PartnerHospital partner in Rio de Janeiro providing imaging, nuclear medicine, chemotherapy, radiotherapy, emergency, and 24-hour inpatient services (252 beds, 172 apartments, 57 ICU, 23 semi-intensive). Used for clinical study procedures and patient treatment.
• Hospital Paulistano (São Paulo)coreStrategic or Co-development PartnerSão Paulo hospital partner providing emergency, inpatient (125 beds), ICU (20 beds), oncology outpatient clinic (21 chairs), imaging, consultations, and chemotherapy treatment. Houses the oncology pharmacy for clinical study medications.
• Hospital Samaritano (Rio de Janeiro)supportingStrategic or Co-development PartnerPartner hospital in Rio de Janeiro for neurology services. Dr. Felipe Schmidt serves as Coordinator of the Neurology Service at Samaritano and Vitória Hospitals.
• Richet (Rio de Janeiro)supportingTechnology or IntegrationClinical analysis laboratory partner for diagnostic testing services supporting clinical studies at the Rio de Janeiro unit.
• Delboni Auriemo (São Paulo)supportingTechnology or IntegrationLaboratory partner for clinical analysis services at the São Paulo unit, located within Hospital Paulistano.
• HCOR (São Paulo)supportingStrategic or Co-development PartnerPartner hospital in São Paulo providing radiotherapy services for clinical study patients.
• Cedimen (São Paulo)supportingTechnology or IntegrationPartner facility for bone scintigraphy (cintilografia óssea) services supporting clinical studies at the São Paulo unit.
• Giovanna Antonelli (as madrinha/godmother)minorGTM or Marketing PartnerBrazilian actress serving as godmother (madrinha) of the Banco de Perucas project, providing public visibility and support for the wig bank initiative.
• NovartissupportingGTM or Marketing PartnerPharmaceutical company partner supporting Horizontes da Saúde patient education events (Multiple Sclerosis event, Aug 2025) and podcast content (Raízes episode on myelofibrosis). Also partner in Simpósio Internacional Oncologia Americas.
• MercksupportingGTM or Marketing PartnerPharmaceutical company providing support for Horizontes da Saúde patient education events.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hospital Israelita Albert Einstein: Brazilian hospital network that operates a leading clinical research institute (Einstein Research Center) running multi-specialty trials and physician education programs parallel to Instituto Américas.
• DASA: Brazil's largest diagnostics company (Delboni Auriemo, a partner of Instituto Américas) that operates its own clinical research arm and competes for trial-enabling laboratory and patient-recognition infrastructure.
• Oncoclínicas: Largest Brazilian oncology clinic network with private-pay oncology treatment and growing clinical research operations, comparable to Americas Oncologia as a competing integrated cancer-care and trial platform.
• Hospital Sírio-Libanês: High-complexity Brazilian tertiary hospital with an active clinical research and continuing education program that competes for sponsored trials and CME audiences similar to Instituto Américas.
• A.C. Camargo Cancer Center: Major Brazilian oncology hospital with dedicated research, education, and clinical trial programs covering oncology and hematology, making it the most direct institutional peer for Instituto Américas.
• Hospital de Câncer de Barretos: Brazilian cancer hospital with an extensive clinical research program in oncology, conducting Phase II/III trials and publishing real-world outcomes comparable to Instituto Américas' oncology and hematology trial operations.
• Hospital Moinhos de Vento: Brazilian hospital with an established clinical research center (IEP Moinhos) running multi-specialty sponsored trials and education programs, comparable to Instituto Américas as a hospital-integrated research site.

Broad incumbents

• IQVIA: Global CRO/clinical research services leader; while not a single-site peer, it competes for the same sponsor trial placement budgets that Instituto Américas relies on and sets the bar for trial operations.
• ICON plc: Global clinical research organization (post-PRA merger) offering sponsor-facing and site-facing services, comparable as a competitor for sponsored clinical trial contracts in oncology.

Others

• Eurofarma: Major Brazilian pharmaceutical company that sponsors trials at sites like Instituto Américas; comparable as a counterparty/market-shaping sponsor rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AmericasInstituto

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Americas